Netherlands (Kingdom of the) vs Switzerland: Percentage of bloodstream infection due to methicillin-resistant
Netherlands (Kingdom of the)
2.3%
in 2022
Switzerland
4.1%
in 2022
Netherlands (Kingdom of the) rank
47th
Switzerland rank
44th
Percentage of bloodstream infection due to methicillin-resistant over time
- Netherlands (Kingdom of the)
- Switzerland
How they compare
Switzerland currently reports 4.1% against 2.3% in Netherlands (Kingdom of the), a difference of 1.8%.
That makes Switzerland's figure about 1.8 times Netherlands (Kingdom of the)'s.
Across all 6 years both countries report, Switzerland has been ahead every year.
Netherlands (Kingdom of the) ranks 47th and Switzerland ranks 44th of 50 countries.
Switzerland has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Netherlands (Kingdom of the) | Switzerland | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 1.4% | 4.8% | 3.4% | Switzerland |
| 2020s | 1.8% | 11.1% | 9.3% | Switzerland |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher percentage of bloodstream infection due to methicillin-resistant, Netherlands (Kingdom of the) or Switzerland?
- Switzerland, at 4.1% against 2.3% in Netherlands (Kingdom of the) as of 2022.
- What is the difference in percentage of bloodstream infection due to methicillin-resistant between Netherlands (Kingdom of the) and Switzerland?
- 1.8%, with Switzerland ahead.
- How many years of comparable data are there for Netherlands (Kingdom of the) and Switzerland?
- 6 years are reported by both, from 2017 to 2022.
- How do Netherlands (Kingdom of the) and Switzerland rank globally for percentage of bloodstream infection due to methicillin-resistant?
- Netherlands (Kingdom of the) ranks 47th and Switzerland ranks 44th of 50 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.